Here, we first demonstrated that the upregulation of MIR210HG in malignant tissues of ovarian cancer patients and MIR210HG high expression was correlated with tumor progression and poor prognosis of ovarian cancer patients, which suggested that MIR210HG is a potential prognostic predictor for ovarian cancer patients. Here, MIR210HG is linked to ovarian cancer.